Physician

Xiaoyan Wang, M.D.

According to 2025 Medicare claims, Xiaoyan Wang, M.D. (NPI: 1912110255) practices hematology/oncology in the Washington, DC-MD market, with the plurality of this provider's patient population coming from Prince Georges, MD. This provider's primary affiliated billing organization is CHITRA VENKATRAMAN, M.D., P.A. (NPI: 1962431718; TIN: 522208885) and primary practice location at 20770-2279.

Wang's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 476 traditional Medicare patients, billed 84,456 HCPCS/CPT codes, and received $1,545,948 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 614 prescription claims across 141 beneficiaries totaling $2,452,977 in drug costs, led by Pomalyst (Pomalidomide). Open Payments data shows 44 records totaling $1,121. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $47,120 to $1,545,948. Similarly, Part D prescription costs have moved sharply higher in recent years, from $125,506 to $2,452,977. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	135	4,774	$47,120
2016	351	10,234	$198,768
2017	374	21,528	$360,059
2018	399	39,586	$642,137
2019	387	30,659	$729,495
2020	413	37,705	$841,937
2021	417	75,306	$1,530,555
2022	421	85,689	$1,615,189
2023	398	62,916	$1,177,647
2024	476	84,456	$1,545,948

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	76	225	$125,506
2016	70	193	$71,488
2017	79	302	$259,598
2018	89	277	$296,923
2019	68	223	$680,028
2020	77	277	$925,499
2021	83	363	$1,351,173
2022	103	463	$2,026,061
2023	102	438	$1,893,521
2024	141	614	$2,452,977

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	107	107	$149
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	265	505	$113
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	335	1,006	$80
96372	Injection of drug or substance under skin or into muscle	62	310	$13
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	414	1,499	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Pomalyst	Pomalidomide	26	728	$535,957
Lenalidomide	Lenalidomide	39	889	$419,830
Calquence	Acalabrutinib Maleate	18	530	$272,878
Erleada	Apalutamide	11	330	$156,799
Eliquis	Apixaban	183	7,070	$136,051

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	44	$1,121	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Xiaoyan Wang, M.D.?

Tedicare shows public-source Medicare data for Xiaoyan Wang, M.D. (NPI 1912110255), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Xiaoyan Wang, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Xiaoyan Wang, M.D.?

Xiaoyan Wang, M.D. is linked to CHITRA VENKATRAMAN, M.D., P.A. (billing NPI 1962431718) in the available physician profile data.

Does Xiaoyan Wang, M.D. have Open Payments data?

Xiaoyan Wang, M.D. has 44 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.